Previous close | 49.91 |
Open | 49.67 |
Bid | 0.00 x 900 |
Ask | 0.00 x 800 |
Day's range | 49.19 - 49.75 |
52-week range | 40.38 - 51.30 |
Volume | |
Avg. volume | 796,841 |
Market cap | 11.226B |
Beta (5Y monthly) | 0.39 |
PE ratio (TTM) | 24.77 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VENLO, The Netherlands, January 17, 2023--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of EZ2 Connect MDx for use in diagnostic laboratories, making the IVD platform for automated sample processing available for widescale use 18 months after being made available for research.
VENLO, Netherlands, January 17, 2023--QIAGEN N.V. to release results for Q4 and Full-Year results 2022 and hold webcast
VENLO, The Netherlands & SAN DIEGO, January 09, 2023--QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.